As the deadline for reauthorization of this program, known as PEPFAR, nears on Sept. 30, Congress should recognize that it has not only been a beacon of hope for millions of people affected by HIV/AIDS but also a powerful tool for expanding U.S. power projection and influence around the world.
The success of PEPFAR is nothing short of remarkable. Over the years, it has provided antiretroviral treatment to over 14 million people, preventing countless deaths and improving the lives for those with HIV/AIDS. PEPFAR’s support for prevention programs, including initiatives focused on mother-to-child transmission, has significantly reduced new infections.
This approach fosters goodwill and strengthens diplomatic ties with countries that benefit from PEPFAR’s support. It creates a foundation for broader engagement and cooperation on global issues such as public health, economic development and security. While PEPFAR’s accomplishments are undeniable, it is crucial to acknowledge that the fight against HIV/AIDS is far from over. The program’s continued success depends on sustained funding and continued commitment. Furthermore, the lessons learned from PEPFAR can serve as a model for addressing other global health challenges and reinforcing American leadership in the 21st century.